Title 16, HEALTH

Sec. 13. (a) The state department shall adopt rules under IC 4-22-2 that establish a schedule of civil penalties that may be levied in an action to enforce the provisions of the following: (1) This chapter. (2) The rules of the state department. (b) A penalty included in the sche…

Sec. 14. The owner or operator of an agricultural labor camp may under 29 U.S.C. 1821(c) impose a penalty on an agricultural laborer who knowingly or intentionally destroys or damages property on the premises of an agricultural labor camp. [Pre-1993 Recodification Citation: 13-1-…

Sec. 15. A construction permit issued by the state department for an agricultural labor camp under 410 IAC 6-9 is issued in accordance with IC 16-19-3.5. As added by P.L.49-2016, SEC.2.

Sec. 2. A person operating or maintaining an agricultural labor camp shall comply with this chapter and rules adopted under this chapter. [Pre-1993 Recodification Citation: 13-1-9-2.] As added by P.L.2-1993, SEC.24.

Sec. 3. (a) Except as provided in subsection (b), a person may not directly or indirectly operate an agricultural labor camp until the person has obtained from the state department a permit to operate the camp and unless the permit is in full force and effect and is posted and ke…

Sec. 4. (a) In addition to a permit issued under section 6 of this chapter, the state department may issue a permit that is limited to at least one (1) specific living unit of an agricultural labor camp. The state may issue more than one (1) permit under this section to a person …

Sec. 5. The state department may issue a permit under section 4 of this chapter only if: (1) all mobile homes used as shelters and equipped with an operable toilet, shower, lavatory, and hot and cold water under pressure, provide a minimum floor space of sixty (60) square feet fo…

Sec. 6. (a) An application to operate an agricultural labor camp must be made to the state department in writing on a form and under rules prescribed by the state department. (b) The state department shall issue a permit for the operation of an agricultural labor camp if the stat…

Sec. 7. The state department may, after reasonable notice and opportunity for a fair hearing in accordance with IC 4-21.5-3, revoke a permit authorizing the operation of an agricultural labor camp if the state department finds that the holder of the permit has failed to comply wi…

Note: This version of section effective until 7-1-2027. See also following version of this section, effective 7-1-2027. Sec. 8. (a) Except as provided in subsection (b), the state department shall adopt rules under IC 4-22-2 necessary to protect the health, safety, and welfare of…

Sec. 9. (a) The state department may initiate an action under IC 4-21.5-3-6 or IC 4-21.5-3-8 to enforce this chapter and rules adopted under this chapter. (b) The state department and the state department's authorized representatives may enter and inspect agricultural labor camps…

Sec. 1. (a) This chapter does not affect IC 5-10-8-15, IC 12-15-5-9.2, IC 27-8-25, or IC 27-13-7-20.2. (b) This chapter does not require a manufacturer to make available any investigational drug, biological product, or device. As added by P.L.2-2015, SEC.3.

Sec. 2. As used in this chapter, "investigational drug, biological product, or device" means an investigational or experimental: (1) drug; (2) biological product; or (3) medical device; that has successfully completed Phase I of a federal Food and Drug Administration approved cli…

Sec. 3. As used in this chapter, "qualified patient" means a patient who meets the requirements under IC 25-22.5-1-2.1(a). As added by P.L.2-2015, SEC.3.

Sec. 4. (a) A manufacturer of an investigational drug, biological product, or device may make available the investigational drug, biological product, or device to a qualified patient. (b) A manufacturer may do any of the following: (1) Provide an investigational drug, biological …

Sec. 5. This chapter does not create a cause of action against a manufacturer of an investigational drug, biological product, or device for any harm to a qualified patient resulting from use of an investigational drug, biological product, or device. As added by P.L.2-2015, SEC.3.